Meta-analysis showed that lung cancer is associated with a very mild effect on modulation of expression of ACE2 (SMD = −0.16, P = 0.0038) and cathepsin L (SMD = −0.18, P = 0.0011) (Figure 6). The gene discussed is ACE2; the disease is lung carcinoma.